News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Stem Cell Therapy International Corp. Announces Major Obstacles Cleared for Merger With Histostem, Co., Ltd.
December 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TAMPA, FL--(Marketwire - December 11, 2008) - Stem Cell Therapy International Inc. (OTCBB: SCII)
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Mergers & acquisitions
Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts
December 9, 2024
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
·
2 min read
·
Tristan Manalac
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
·
1 min read
·
Kate Goodwin
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
·
2 min read
·
Heather McKenzie
